DMRA · Insider Trading
Damora Therapeutics, Inc. Ordinary Shares
Every open-market purchase and sale reported by DMRA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | Jennifer Jarrett | Director, President and CEO | Buy | +12,500 | +$252.88K |
| 2026-08-13 | Andrew Cheng | Director | A | +30,350 deriv. | — |
| 2026-07-07 | Garrett Winslow | General Counsel | MIXED | +435 | −$7.35K |
| 2026-04-01 | Jennifer Jarrett | See Remarks | A | +500,000 | — |
| 2026-03-25 | Michael Landsittel | Director | A | +37,313 deriv. | — |
| 2026-03-25 | Cameron Turtle | Director | A | +37,313 deriv. | — |
| 2026-03-25 | Julianne Bruno | Director | A | +37,313 deriv. | — |
| 2026-03-25 | Garrett Winslow | General Counsel | A | +250,000 deriv. | — |
| 2026-03-25 | Fairmount Healthcare Fund II L.P. | Director | A | +186,565 deriv. | — |
| 2026-03-25 | Christopher W. Cain | Director | A | +37,313 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Jennifer Jarrett | Director, President and CEO | 512,500 | $10.90M |
| Garrett Winslow | General Counsel | 2,534 | $53.87K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DMRA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.